Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety trial of GB-0998 for generalized myasthenia gravis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis
• Myasthenia Gravis

Drugs mentioned

• GB-0998

Snippet

Sponsor: Benesis Corporation | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: COMPLETED